TY - JOUR
T1 - PRISMA (Preferred reporting items for systematic reviews and meta-analyses) extension for Chinese herbal medicines 2020 (PRISMA-CHM 2020)
AU - Zhang, Xuan
AU - Tian, Ran
AU - Lam, Wai Ching
AU - Yao, Liang
AU - Wang, Xiaoqin
AU - Cheng, Chung Wah
AU - Liu, Fan
AU - Chan, Jacky Chun Pong
AU - Aixinjueluo, Qiying
AU - Lau, Chung Tai
AU - Chen, Yaolong
AU - Yang, Kehu
AU - Wu, Taixiang
AU - Lyu, Aiping
AU - Bian, Zhaoxiang
N1 - Funding Information:
The authors thank all those who contributed to the development of PRISMA-CHM, both in its draft and final forms. We also thank Dr. Martha Dahlen for her critical editing. Special thanks for the financial support from Fong Shu Fook Tong Foundation, Hong Kong.
PY - 2020/9/9
Y1 - 2020/9/9
N2 - Chinese Herbal Medicines (CHM) are the most common interventions of traditional Chinese medicine (TCM), typically administered as either single herbs or formulas. Systematic reviews (SRs) are essential references for evaluating the efficacy and safety of CHM treatments accurately and reliably. Unfortunately, the reporting quality of SRs with CHM is not optimal, especially the reporting of CHM interventions and the rationale of why these interventions were selected. To address this problem, a group of TCM clinical experts, methodologists, epidemiologists, and editors has developed a PRISMA extension for CHM interventions (PRISMA-CHM) through a comprehensive process, including registration, literature review, consensus meeting, three-round Delphi survey, and finalization. The PRISMA checklist was extended by introducing the concept of TCM Pattern and the characteristics of CHM interventions. A total of twenty-four items (including sub-items) are included in the checklist, relating to title (1), structured summary (2), rationale (3), objectives (4), eligibility criteria (6), data items (11), synthesis of results (14, 21), additional analyses (16, 23), study characteristics (18), summary of evidence (24), and conclusions (26). Illustrative examples and explanations are also provided. The group hopes that PRISMA-CHM 2020 will improve the reporting quality of SRs of CHM.
AB - Chinese Herbal Medicines (CHM) are the most common interventions of traditional Chinese medicine (TCM), typically administered as either single herbs or formulas. Systematic reviews (SRs) are essential references for evaluating the efficacy and safety of CHM treatments accurately and reliably. Unfortunately, the reporting quality of SRs with CHM is not optimal, especially the reporting of CHM interventions and the rationale of why these interventions were selected. To address this problem, a group of TCM clinical experts, methodologists, epidemiologists, and editors has developed a PRISMA extension for CHM interventions (PRISMA-CHM) through a comprehensive process, including registration, literature review, consensus meeting, three-round Delphi survey, and finalization. The PRISMA checklist was extended by introducing the concept of TCM Pattern and the characteristics of CHM interventions. A total of twenty-four items (including sub-items) are included in the checklist, relating to title (1), structured summary (2), rationale (3), objectives (4), eligibility criteria (6), data items (11), synthesis of results (14, 21), additional analyses (16, 23), study characteristics (18), summary of evidence (24), and conclusions (26). Illustrative examples and explanations are also provided. The group hopes that PRISMA-CHM 2020 will improve the reporting quality of SRs of CHM.
KW - Chinese Herbal Medicine
KW - Extension
KW - PRISMA
KW - Recommendation
KW - Reporting Quality
KW - Review
UR - http://www.scopus.com/inward/record.url?scp=85091873599&partnerID=8YFLogxK
U2 - 10.1142/S0192415X20500639
DO - 10.1142/S0192415X20500639
M3 - Journal article
C2 - 32907365
AN - SCOPUS:85091873599
SN - 0192-415X
VL - 48
SP - 1279
EP - 1313
JO - The American Journal of Chinese Medicine
JF - The American Journal of Chinese Medicine
IS - 6
ER -